Do Latent Autoimmune Diabetes of the Adult (LADA) Patients Require Insulin at Diagnosis?
Response to Pozzilli and Di Mario
- Barbara Szepietowska, MD1,
- Malgorzata Szelachowska, PHD2 and
- Ida Kinalska, PHD2
- 1“Angela Valenti” Laboratory of Genetic and Enviromental Risk Factors for Thrombotic Disease, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
- 2Department of Internal Medicine, Diabetology and Endocrinology, Medical Academy, Bialystok, Poland
In the August 2001 issue of Diabetes Care, Paolo Pozzilli and Umberto Di Mario (1) present their current opinion about the definition, characterization, and potential prevention of latent autoimmune diabetes in adults (LADA). We read their article with great interest, especially as it concerns different treatments of patients with LADA. Because 10–15% of adult diabetic patients may have autoimmune diabetes, management in this group seems to be a very important question. Yet, we do not fully concur …
